You have %itemCount% in your cart. Total being %total%
Andexxa Vs 4F-PCC in ICH: An Ongoing Debate
November 28, 2022
BACKGROUND: Direct oral anticoagulants (DOACs) such as rivaroxaban [Xarelto] and apixaban [Eliquis] have become more prevalent in the aging population and are associated with intracranial...
Marco Torres
Andexanet Alfa Vs. Four-Factor PCC: Is Andexanet Alfa Worth The Hype?
February 28, 2022
Background: Oral factor Xa inhibitors (FXi) have been associated with major and fatal bleeding events, including intracranial hemorrhage (ICH). In randomized controlled trials, both rivaroxaban...